Moreover, we showed that treatment with BCLXL inhibitor (A-1331852) or deficiency of the BCLXL gene induces cell death upon infection with flaviviruses in several cancer cell lines and primary MEFs. The gene discussed is BCL2L1; the disease is cancer.